» Articles » PMID: 23970445

Low-level Laser (light) Therapy (LLLT) for Treatment of Hair Loss

Overview
Journal Lasers Surg Med
Date 2013 Aug 24
PMID 23970445
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Alopecia is a common disorder affecting more than half of the population worldwide. Androgenetic alopecia, the most common type, affects 50% of males over the age of 40 and 75% of females over 65. Only two drugs have been approved so far (minoxidil and finasteride) and hair transplant is the other treatment alternative. This review surveys the evidence for low-level laser therapy (LLLT) applied to the scalp as a treatment for hair loss and discusses possible mechanisms of actions.

Methods And Materials: Searches of PubMed and Google Scholar were carried out using keywords alopecia, hair loss, LLLT, photobiomodulation.

Results: Studies have shown that LLLT stimulated hair growth in mice subjected to chemotherapy-induced alopecia and also in alopecia areata. Controlled clinical trials demonstrated that LLLT stimulated hair growth in both men and women. Among various mechanisms, the main mechanism is hypothesized to be stimulation of epidermal stem cells in the hair follicle bulge and shifting the follicles into anagen phase.

Conclusion: LLLT for hair growth in both men and women appears to be both safe and effective. The optimum wavelength, coherence and dosimetric parameters remain to be determined.

Citing Articles

Lasers for treatment of androgenetic alopecia: an in-depth analysis.

Gupta A, Taylor D, Nouri K Lasers Med Sci. 2025; 40(1):108.

PMID: 39979533 DOI: 10.1007/s10103-025-04365-3.


Human-Centric, Three Dimensional Micro Light-Emitting Diodes for Cosmetic and Medical Phototherapy.

Nam K, Kim M, An J, Min S, Lee J, Park J Adv Sci (Weinh). 2025; 12(10):e2416716.

PMID: 39960366 PMC: 11905057. DOI: 10.1002/advs.202416716.


Impact of short and long-term application of low-level laser therapy on mandibular alveolar process of osteoporotic rats - a Histological and Molecular Study.

El-Halwagy M, Hegazy E, Shalaby H, Mahmoud E Lasers Med Sci. 2025; 40(1):5.

PMID: 39751945 PMC: 11698838. DOI: 10.1007/s10103-024-04246-1.


hair growth-promoting effects of araliadiol via the p38/PPAR-γ signaling pathway in human hair follicle stem cells and dermal papilla cells.

Park S, Park H, Seo D, Yoo D, Bae S Front Pharmacol. 2024; 15:1482898.

PMID: 39691387 PMC: 11649413. DOI: 10.3389/fphar.2024.1482898.


Chemotherapy-Induced Alopecia by Docetaxel: Prevalence, Treatment and Prevention.

Perez A, Haberland N, Miteva M, Wikramanayake T Curr Oncol. 2024; 31(9):5709-5721.

PMID: 39330051 PMC: 11431623. DOI: 10.3390/curroncol31090423.


References
1.
Itami S, Inui S . Role of androgen in mesenchymal epithelial interactions in human hair follicle. J Investig Dermatol Symp Proc. 2005; 10(3):209-11. DOI: 10.1111/j.1087-0024.2005.10107.x. View

2.
Hou Y, Janczuk A, Wang P . Current trends in the development of nitric oxide donors. Curr Pharm Des. 1999; 5(6):417-41. View

3.
Castex-Rizzi N, Lachgar S, Charveron M, Gall Y . [Implication of VEGF, steroid hormones and neuropeptides in hair follicle cell responses]. Ann Dermatol Venereol. 2002; 129(5 Pt 2):783-6. View

4.
Muller-Rover S, Handjiski B, van der Veen C, Eichmuller S, Foitzik K, McKay I . A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages. J Invest Dermatol. 2001; 117(1):3-15. DOI: 10.1046/j.0022-202x.2001.01377.x. View

5.
Pinfildi C, Hochman B, Nishioka M, Sheliga T, Neves M, Liebano R . What is better in TRAM flap survival: LLLT single or multi-irradiation?. Lasers Med Sci. 2012; 28(3):755-61. DOI: 10.1007/s10103-012-1130-3. View